Unknown PHASE1 INTERVENTIONAL 3-arm NCT03234673

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

The Effect of Preceding Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or With NB-UVB in the Treatment of Stable Generalized Vitiligo

Sponsor: Assiut University

Conditions Vitiligo Vulgaris

Interventions NB-UVB Tacrolimus ointment calcipotriol ointment

Updated 6 times since 2017 Last updated: Jul 30, 2017 Started: Aug 31, 2017 Primary completion: Aug 31, 2018 Completion: Jan 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Vitiligo Vulgaris, this trial is ongoing. The trial is conducted by Assiut University and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Aug 2019 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting PHASE1

▶ Show 1 earlier version

Aug 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.